Type 2 diabetes mellitus (T2DM) is recognized as a metabolic syndrome, primarily marked by insufficient insulin caused by pancreatic β-cell dysfunction and insulin resistance in target organs (NCD Risk Factor Collaboration NCD-RisC, 2016; Sudesna et al., 2017). This evidence concerns the gene INS and type 2 diabetes mellitus.